Status:
COMPLETED
Liver Enzyme Abnormalities and Risk Factors in Taking Herbal Medicine
Lead Sponsor:
Jaseng Hospital of Korean Medicine
Conditions:
Drug-Induced Liver Injury
Musculoskeletal Diseases
Eligibility:
All Genders
Brief Summary
Herb-induced liver injury is an important issue in musculoskeletal diseases where herbal medicine is most frequently used. The low prevalence of drug-induced liver injury (DILI) gives rise to the need...
Detailed Description
Herb-induced liver injury is an important issue in musculoskeletal diseases where herbal medicine is most frequently used. The low prevalence of drug-induced liver injury (DILI) gives rise to the need...
Eligibility Criteria
Inclusion
- Patients admitted for at least one day who took herbal medicine and at least 2 LFTs during admittance.
Exclusion
- None.
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
6894 Patients enrolled
Trial Details
Trial ID
NCT02299739
Start Date
December 1 2005
End Date
December 1 2013
Last Update
November 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jaseng Hospital of Korean Medicine
Seoul, Gangnam-Gu, South Korea, 135-896